Valuation: Kintor Pharmaceutical Limited

Market Cap 58Cr 69Cr 8.75Cr 7.93Cr 7.33Cr 6.62Cr 12Cr 824.92Cr 13Cr 88Cr 35Cr 440.66Cr 33Cr 32Cr 1.4TCr P/E 2024
-2.53x
P/E 2025 -3.96x
Enterprise Value 64Cr 75Cr 9.56Cr 8.66Cr 8.01Cr 7.23Cr 14Cr 901Cr 14Cr 96Cr 38Cr 481.3Cr 36Cr 35Cr 1.53TCr EV / Sales 2024
7,57,94,130x
EV / Sales 2025 2,82,45,180x
Free-Float
87.95%
Yield 2024 *
-
Yield 2025 -
1 day-4.32%
1 week-4.66%
Current month-1.48%
1 month-11.63%
3 months-28.30%
6 months-52.33%
Current year-32.14%
1 week 1.31
Extreme 1.31
1.54
1 month 1.21
Extreme 1.21
1.74
Current year 1.21
Extreme 1.21
4.7
1 year 1.21
Extreme 1.21
4.7
3 years 0.79
Extreme 0.79
4.7
5 years 0.79
Extreme 0.79
64
10 years 0.79
Extreme 0.79
89
Manager TitleAgeSince
Chief Executive Officer 64 24/03/2009
Director of Finance/CFO 48 21/09/2026
Chief Tech/Sci/R&D Officer 49 01/09/2020
Director TitleAgeSince
Director/Board Member 62 12/08/2019
Director/Board Member 61 12/08/2019
Chairman 64 24/03/2009
Date Insider Type Main position Quantity % Market Cap. Importance
16/10/26 Other

Chief Executive Officer

1,00,000 0.0201%
15/10/26 Other

Chief Executive Officer

1,00,000 0.0201%
17/07/26 Other

Chief Executive Officer

1,45,000 0.0291%
Change 5-day change 1-year change 3-year change Capi.($)
-4.32%-4.66%-38.43%-53.50% 8.75Cr
-2.69%-0.48%+53.97%+66.82% 6.63TCr
+0.20%+3.09%+11.08%+95.60% 6.06TCr
+0.96%+2.00%+24.69%+90.38% 5.55TCr
+0.14%+2.35%+13.86%+111.94% 4.76TCr
-2.21%-2.47%+20.18%+28.81% 4.37TCr
-2.30%-10.40%+154.30%+707.36% 3.73TCr
+2.15%+1.42%+14.58%+48.71% 3.66TCr
+2.67%-3.47%+78.89%+60.93% 3.22TCr
+2.62%+5.90%-37.29%+386.59% 2.66TCr
Average -0.28%+0.12%+29.58%+154.36% 4TCr
Weighted average by Cap. -0.14%+0.20%+36.89%+153.04%

Financials

2024 2025
Net sales 5 5.88 0.75 0.68 0.63 0.57 1.07 70.63 1.11 7.54 2.99 37.73 2.81 2.75 119.76 32.68 38.41 4.9 4.44 4.1 3.7 6.98 461.65 7.22 49.3 19.55 246.6 18.37 17.98 782.78
Net income -16Cr -18Cr -2.33Cr -2.11Cr -1.95Cr -1.76Cr -3.32Cr -219.36Cr -3.43Cr -23Cr -9.29Cr -117.18Cr -8.73Cr -8.55Cr -371.95Cr -20Cr -24Cr -3Cr -2.72Cr -2.51Cr -2.27Cr -4.27Cr -282.66Cr -4.42Cr -30Cr -12Cr -150.99Cr -11Cr -11Cr -479.29Cr
Net Debt -1.57Cr -1.84Cr -23.49L -21.29L -19.69L -17.76L -33.48L -22Cr -34.66L -2.37Cr -93.78L -12Cr -88.15L -86.28L -38Cr 5.39Cr 6.33Cr 80.69L 73.12L 67.63L 61.02L 1.15Cr 76Cr 1.19Cr 8.12Cr 3.22Cr 41Cr 3.03Cr 2.96Cr 129.01Cr
Projected Income Statement - Annual - Kintor Pharmaceutical Limited
Logo Kintor Pharmaceutical Limited
Kintor Pharmaceutical Ltd is an investment holding company primarily engaged in the research and development of innovative medicine products. The Company's products are dedicated to addressing disease areas that have not met clinical needs, and its pipeline mainly covers indications of dermatology (such as androgenetic alopecia, acne vulgaris) and indications of tumors. The Company has two core drugs in the dermatology field, KX-826 and GT20029. The Company's other disease areas include metastatic castration-resistant prostate cancer (mCRPC), liver cancer, idiopathic pulmonary fibrosis, malignant blood diseases and various solid tumors.
Employees
122
Date Price Change Volume
16/26/16 HK$1.330 -4.32% 7,47,000
13/26/13 HK$1.390 +1.09% 9,81,000
12/26/12 HK$1.375 -2.48% 2,78,500
11/26/11 HK$1.410 +1.81% 2,94,000
10/26/10 HK$1.385 -0.72% 14,96,000

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kintor Pharmaceutical Limited
  1. Stock Market
  2. Stocks
  3. 9939 Stock